COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
Kaminski et al., Kidney International, doi:10.1016/j.kint.2022.07.008
https://c19early.org/kaminski.html